Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 4.04 is 34% below its 5-year average of 6.09, near the low end of its 5-year range (1.71–30.87).
As of the fiscal period ended Tuesday, June 30, 2026. 0.05% above its 12-month average of 4.04.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 4.04.
QUICK RATIO (ACID-TEST)
4.04
QUICK RATIO (ACID-TEST) AVG TTM
4.04
QUICK RATIO (ACID-TEST) AVG 3Y
3.23
QUICK RATIO (ACID-TEST) AVG 5Y
6.09
QUICK RATIO (ACID-TEST) AVG 10Y
7.89
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+0.05%
CURRENT VS 3Y AVG
+25.05%
CURRENT VS 5Y AVG
-33.66%
CURRENT VS 10Y AVG
-48.80%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.30
median of 822 covered companies
CURRENT VS SECTOR MEDIAN
+22.44%
vs the sector median at left
INmune Bio, Inc.
Market Cap
$49.45M
Quick Ratio (Acid-Test)
4.04
TTM Avg
4.04
3Y Avg
3.23
5Y Avg
6.09
Market Cap
$49.55M
Quick Ratio (Acid-Test)
4.44
TTM Avg
7.28
3Y Avg
7.49
5Y Avg
6.53
Market Cap
$49.32M
Quick Ratio (Acid-Test)
0.96
TTM Avg
1.17
3Y Avg
2.45
5Y Avg
4.99
Market Cap
$49.67M
Quick Ratio (Acid-Test)
17.82
TTM Avg
12.77
3Y Avg
7.97
5Y Avg
9.78
Market Cap
$49.21M
Quick Ratio (Acid-Test)
2.38
TTM Avg
3.89
3Y Avg
3.83
5Y Avg
5.36
Market Cap
$49.79M
Quick Ratio (Acid-Test)
0.08
TTM Avg
0.22
3Y Avg
0.27
5Y Avg
0.92
Market Cap
$50.45M
Quick Ratio (Acid-Test)
3.74
TTM Avg
0.21
3Y Avg
0.34
5Y Avg
1.39
Market Cap
$48.32M
Quick Ratio (Acid-Test)
5.74
TTM Avg
9.62
3Y Avg
7.35
5Y Avg
7.40
Market Cap
$48.27M
Quick Ratio (Acid-Test)
1.84
TTM Avg
1.45
3Y Avg
1.28
5Y Avg
1.17
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| INmune Bio, Inc. (INMB) | $49.45M | 4.04 | 4.04 | 3.23 | 6.09 |
| Sensus Healthcare, Inc. (SRTS)vs › | $49.55M | 4.44 | 7.28 | 7.49 | 6.53 |
| Apollomics, Inc. (APLM)vs › | $49.32M | 0.96 | 1.17 | 2.45 | 4.99 |
| Microbot Medical Inc. (MBOT)vs › | $49.67M | 17.82 | 12.77 | 7.97 | 9.78 |
| TELA Bio, Inc. (TELA)vs › | $49.21M | 2.38 | 3.89 | 3.83 | 5.36 |
| Celularity Inc. (CELU)vs › | $49.79M | 0.08 | 0.22 | 0.27 | 0.92 |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $50.45M | 3.74 | 0.21 | 0.34 | 1.39 |
| Lite Strategy, Inc. (LITS)vs › | $48.32M | 5.74 | 9.62 | 7.35 | 7.40 |
| Precision Optics Corporation, Inc. (POCI)vs › | $48.27M | 1.84 | 1.45 | 1.28 | 1.17 |
| Clene Inc. (CLNN)vs › | $50.61M | 3.07 | 1.20 | 1.50 | 3.41 |
Quick Ratio
4.04
Excludes inventory
Current Ratio
4.04
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 4.04 |
| 2026-03-31 | 4.24 |
| 2025-12-31 | 3.55 |
| 2025-09-30 | 4.17 |
| 2025-06-30 | 4.20 |
| 2025-03-31 | 2.64 |
| 2024-12-31 | 3.14 |
| 2024-09-30 | 2.59 |
| 2024-06-30 | 2.36 |
| 2024-03-31 | 1.71 |
| 2023-12-31 | 2.16 |
| 2023-09-30 | 3.18 |
| 2023-06-30 | 4.03 |
| 2023-03-31 | 5.53 |
| 2022-12-31 | 5.92 |
| 2022-09-30 | 9.67 |
| 2022-06-30 | 30.87 |
| 2022-03-31 | 23.89 |
| 2021-12-31 | 18.95 |
| 2021-09-30 | 18.90 |
| 2021-06-30 | 14.74 |
| 2021-03-31 | 22.41 |
| 2020-12-31 | 13.50 |
| 2020-09-30 | 17.73 |
| 2020-06-30 | 5.22 |
| 2020-03-31 | 6.25 |
| 2019-12-31 | 11.09 |
| 2019-09-30 | 16.84 |
| 2019-06-30 | 20.96 |
| 2019-03-31 | 9.13 |
| 2018-12-31 | 1.03 |
| 2018-09-30 | 5.51 |
| 2018-06-30 | 8.79 |
| 2018-03-31 | 11.79 |
| 2017-12-31 | 6.13 |
| 2017-09-30 | 11.04 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
| 2016-12-31 | 0.75 |
| 2016-09-30 | 0.00 |
